June 26, 2012
MSD K.K., AstraZeneca K.K. (AZ), Shionogi, and Kyowa Pharmaceutical Industry announced separately on June 22 that they obtained on the same day approval for their angiotensin converting enzyme (ACE) inhibitors for hypertension in children as an additional indication. These products...read more